Essity B stock holds gains as share buyback and Brazil deal reshape outlook
Published on 08/25/2026 at 12:02 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS
Essity B (SE0009922164) stock was recently quoted with a closing price of SEK 273.50 on Nasdaq Stockholm as of August 24, 2026, with intraday trading around SEK 281.50 and a reported daily gain of 2.93 percent for that session. Market data also indicate gains of 5.10 percent over the past five trading days and 6.37 percent since the start of 2026, signaling a constructive short-term trend for shareholders as of August 24, 2026. In parallel, an alternative euro-denominated quote on Tradegate showed a price of EUR 24.85 for Essity B on the same date, underscoring cross-venue liquidity for international investors.
Share buyback supports Essity B stock
Per recent disclosures, Essity has been executing a SEK 3 billion share buyback program, and during week 34, 2026, the company repurchased 282,790 Class B shares on Nasdaq Stockholm at a weighted average price of SEK 271.40, corresponding to a total value of SEK 76.8 million. This volume of repurchases in week 34, 2026, represents a tangible capital allocation action that can support earnings per share by reducing the share count, especially when executed at levels close to the recent closing price of SEK 273.50. The weighted average repurchase price of SEK 271.40 in week 34, 2026, sits modestly below the August 24, 2026, intraday indication around SEK 281.50, highlighting that the company has been buying back shares at levels slightly below the latest trading range.
For investors, the combination of a sizable SEK 3 billion buyback authorization and steady execution during August 2026 provides a clear signal that management sees value in Essity B shares at current levels. When share repurchases are conducted at prices such as SEK 271.40 during week 34, 2026, while the stock trades around SEK 281.50 as of August 24, 2026, the gap underscores potential incremental value creation per share, assuming stable fundamentals. This dynamic can also help moderate volatility by providing a consistent bid in the market, complementing the stock’s 6.37 percent gain since the start of 2026.
Brazil feminine care deal adds growth angle
Beyond capital allocation, Essity has agreed to acquire a feminine care business in Brazil from a global consumer-health group for US$284 million, strengthening its presence in one of its core hygiene and health categories. According to reporting on August 25, 2026, the agreed purchase price of US$284 million is intended to expand Essity’s footprint in Brazil’s feminine care market and deepen its portfolio in a key growth region. While detailed pro forma financials were not disclosed in the immediate coverage, the transaction size of US$284 million is meaningful against the backdrop of Essity’s existing hygiene and health operations and signals a willingness to deploy capital into growth alongside buybacks.
The strategic logic is that a US$284 million acquisition in Brazil can widen Essity’s scale in feminine care, potentially improving distribution efficiency and brand reach in Latin America. For shareholders following Essity B stock, this adds another growth lever on top of organic expansion and portfolio optimization, complementing the SEK 3 billion share buyback program announced previously. The combination of an active buyback and a targeted acquisition can influence both the earnings profile and the company’s geographic mix, with Brazil representing a significant consumer market where feminine care penetration and premiumization trends offer room for expansion.
Essity hygiene products anchor the business
Essity’s core business spans a broad range of hygiene and health products, including branded feminine care, tissue, and incontinence offerings that serve consumers and institutions globally. Within this portfolio, feminine care stands out as a category where the planned US$284 million Brazilian acquisition is expected to slot in, providing additional volume and brand assets to reinforce Essity’s competitive position. By aligning acquisitions with existing product strengths, the company seeks to leverage its marketing, innovation, and distribution capabilities across regions, which can support scale benefits over time.
In practical terms, the integration of a Brazilian feminine care business into Essity’s existing hygiene portfolio should allow for cross-branding and channel synergies, particularly in modern retail and pharmacy channels where the company already operates. For investors, the product angle matters because it ties the transaction value directly to a category that is central to Essity’s strategy, rather than representing a diversification into unrelated areas. As Essity continues to balance capital returned via buybacks with capital invested into core-product acquisitions, the performance of categories such as feminine care in Brazil will be an important proof point.
Essity B stock price context
Essity B stock’s recent price context shows a Nordic-traded security with meaningful liquidity both on Nasdaq Stockholm and on alternative venues such as Tradegate. As of the most recent completed trading session on August 24, 2026, the last closing price of SEK 273.50 and intraday levels around SEK 281.50 place the shares in the upper portion of their recent trading range, with a 2.93 percent gain for that day and cumulative gains of 5.10 percent over the previous five trading days and 6.37 percent since the start of 2026. The alternative quote at EUR 24.85 on Tradegate on the same date provides a reference point for euro-based investors and highlights that Essity B can be accessed outside Sweden via cross-venue trading.
For retail investors, these figures frame the current state of Essity B stock as of August 24, 2026: a share price in the high SEK 270s to low SEK 280s, short-term performance in the mid-single-digit range over both the week and the year to date, and a company actively engaging in both share buybacks and strategic acquisitions. While broader Swedish equity indices registered mixed moves on August 24, 2026, Essity B’s 2.93 percent daily gain to a quote around SEK 281.50 stood out positively within the domestic benchmark landscape, aligning with the narrative of a stock benefiting from both corporate actions and defensive hygiene and health exposure.
Representative product: feminine care in Brazil
A representative product lens to view Essity’s strategy is its feminine care line, which will be directly impacted by the planned US$284 million acquisition in Brazil. This category includes sanitary protection products tailored to local consumer preferences, often marketed under regional or global brands and distributed through supermarkets, pharmacies, and e-commerce channels. By acquiring an established feminine care franchise in Brazil, Essity gains immediate access to existing brands, customer relationships, and manufacturing or sourcing arrangements, which can accelerate its growth compared with building a presence organically from scratch.
The Brazilian feminine care business targeted by Essity is expected to integrate into the company’s broader hygiene and health product ecosystem, allowing for innovations such as improved materials, packaging, and sustainability features to be rolled out across markets. Investors tracking Essity B stock can view this product-focused move as part of a broader effort to consolidate and expand in categories where the company has longstanding expertise, while also leveraging emerging-market demographics and rising disposable incomes in markets like Brazil.
Essity B stock on Nasdaq Stockholm
As of the most recent completed trading day on August 24, 2026, Essity B stock’s last closing price of SEK 273.50 on Nasdaq Stockholm, combined with intraday trading indications around SEK 281.50 and a 2.93 percent daily gain, encapsulates the current market view of the company’s trajectory. With gains of 5.10 percent over the past five trading days and 6.37 percent since the start of 2026, Essity B has delivered positive returns for investors during 2026 to date, supported by a SEK 3 billion share buyback program and a planned US$284 million acquisition in Brazil’s feminine care market. For now, Essity B remains a Nordic-listed hygiene and health stock whose performance reflects both its defensive category exposure and its ongoing capital allocation decisions.
Fact box
Company: Essity B
ISIN: SE0009922164
Ticker: ESSITY B
Exchange: Nasdaq Stockholm
